Literature DB >> 19001165

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.

Catherine M Roe1, Mark A Mintun, Gina D'Angelo, Chengjie Xiong, Elizabeth A Grant, John C Morris.   

Abstract

OBJECTIVE: To evaluate the cognitive reserve hypothesis by examining whether individuals of greater educational attainment have better cognitive function than individuals with less education in the presence of elevated fibrillar brain amyloid levels. DESIGN, SETTING, AND PARTICIPANTS: Uptake of carbon 11-labeled Pittsburgh Compound B ([(11)C]PiB) was measured for participants assessed between August 15, 2003, and January 8, 2008, at the Washington University Alzheimer's Disease Research Center and diagnosed either as nondemented (n = 161) or with dementia of the Alzheimer type (n = 37). Multiple regression was used to determine whether [(11)C]PiB uptake interacted with level of educational attainment to predict cognitive function. MAIN OUTCOME MEASURES: Scores on the Clinical Dementia Rating sum of boxes, Mini-Mental State Examination, and Short Blessed Test and individual measures from a psychometric battery.
RESULTS: Uptake of [(11)C]PiB interacted with years of education in predicting scores on the Clinical Dementia Rating sum of boxes (P = .003), the Mini-Mental State Examination (P < .001), the Short Blessed Test (P = .03), and a measure of verbal abstract reasoning and conceptualization (P = .02) such that performance on these measures increased with increasing education for participants with elevated PiB uptake. Education was unrelated to global cognitive functioning scores among those with lower PiB uptake.
CONCLUSION: The results support the hypothesis that cognitive reserve influences the association between Alzheimer disease pathological burden and cognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001165      PMCID: PMC2752218          DOI: 10.1001/archneur.65.11.1467

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  23 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

3.  Validation of clinical diagnostic criteria for Alzheimer's disease.

Authors:  J C Morris; D W McKeel; K Fulling; R M Torack; L Berg
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

4.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Authors:  M A Mintun; M E Raichle; M R Kilbourn; G F Wooten; M J Welch
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

5.  A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume.

Authors:  Randy L Buckner; Denise Head; Jamie Parker; Anthony F Fotenos; Daniel Marcus; John C Morris; Abraham Z Snyder
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

6.  Optimization of a fully 3D single scatter simulation algorithm for 3D PET.

Authors:  Roberto Accorsi; Lars-Eric Adam; Matthew E Werner; Joel S Karp
Journal:  Phys Med Biol       Date:  2004-06-21       Impact factor: 3.609

7.  Interaction of neuritic plaques and education predicts dementia.

Authors:  Catherine M Roe; Chengjie Xiong; J Phillip Miller; Nigel J Cairns; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Apr-Jun       Impact factor: 2.703

8.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

9.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

10.  The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline.

Authors:  Elise Caccappolo-Van Vliet; Jennifer Manly; Ming-Xin Tang; Karen Marder; Karen Bell; Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2003-07       Impact factor: 2.892

View more
  102 in total

1.  Cognitive prescriptions.

Authors:  David E Vance; Greg Eagerton; Brenna Harnish; Peggy McKie; Pariya L Fazeli
Journal:  J Gerontol Nurs       Date:  2010-12-22       Impact factor: 1.254

2.  Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Julie C Price; Ronald L Hamilton; Chester A Mathis; William R Paljug; Manik L Debnath; Anne D Cohen; Katsuyoshi Mizukami; Steven T DeKosky; Oscar L Lopez; William E Klunk
Journal:  Acta Neuropathol       Date:  2012-01-24       Impact factor: 17.088

3.  Effects of cognitive reserve depend on executive and semantic demands of the task.

Authors:  R Ryan Darby; Michael Brickhouse; David A Wolk; Bradford C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-06-19       Impact factor: 10.154

4.  Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Authors:  B C Dickerson; T R Stoub; R C Shah; R A Sperling; R J Killiany; M S Albert; B T Hyman; D Blacker; L Detoledo-Morrell
Journal:  Neurology       Date:  2011-04-13       Impact factor: 9.910

Review 5.  Role of HIV in amyloid metabolism.

Authors:  Mario Ortega; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-10       Impact factor: 4.147

6.  Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Authors:  John C Morris; Catherine M Roe; Elizabeth A Grant; Denise Head; Martha Storandt; Alison M Goate; Anne M Fagan; David M Holtzman; Mark A Mintun
Journal:  Arch Neurol       Date:  2009-12

7.  Role of LCF scale as an outcome prognostic index in patients with traumatic brain injury.

Authors:  Elena Rossato; Elisabetta Verzini; Michele Scandola; Federico Ferrari; Silvia Bonadiman
Journal:  Neurol Sci       Date:  2020-10-29       Impact factor: 3.307

Review 8.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012

9.  Comparison of 18F-FDG and PiB PET in cognitive impairment.

Authors:  Val J Lowe; Bradley J Kemp; Clifford R Jack; Matthew Senjem; Stephen Weigand; Maria Shiung; Glenn Smith; David Knopman; Bradley Boeve; Brian Mullan; Ronald C Petersen
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

Review 10.  The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research.

Authors:  David E Vance; Pariya L Fazeli; Joan E Dodson; Michelle Ackerman; Michele Talley; Susan J Appel
Journal:  J Neurosci Nurs       Date:  2014-10       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.